Form 4 for ABT Abbott Laboratories
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0002075371-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-27 | ABT | Cushman Elizabeth C. | EVP, GC AND Sec | F - Tax | $116.26 | -1,421 | 38.8K | -4% | -$165.2K | |
| 2026-03-03 | 2026-03-02 | ABT | Cushman Elizabeth C. | EVP, GC AND Sec | S - Sale | $115.58 | -263 | 38.6K | -0.7% | -$30.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2026-02-27 | F | D | 1,421 | $116.26 | 38,836 | D | — | — | |
| 2 | Common | Common shares without par value | 2026-03-02 | S | D | 263 | $115.58 | 38,573 | D | — | — |